CHRISTOPHER RODRIGUEZ: Open Payments
NPI 1316195878 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,652 in 68 payments from 10 companies in 2025. Trend: 2023 $938 · 2024 $2,629 · 2025 $2,652
Food & beverage: $1,914Travel & lodging: $639Education: $99
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $1,244 |
| ABBVIE INC. | 21 | $511 |
| Janssen Biotech, Inc. | 12 | $447 |
| GlaxoSmithKline, LLC. | 9 | $148 |
| UCB, Inc. | 3 | $111 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| GENZYME CORPORATION | 1 | $33 |
| Genentech USA, Inc. | 1 | $25 |
| Radius Health, Inc. | 1 | $15 |
Products named: TREMFYA, HUMIRA, BENLYSTA, SKYRIZI, RINVOQ, Bimzelx, ORENCIA, COSENTYX.
Industry payments across FL — which companies pay providers there.
